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MANY alkylnitroso compounds are effective carcinogens (Magee and Barnes,
1967) among which N-alkyl-N-nitrosourethanes are particularly interesting as
they are able to induce tumours at the site of application without the need of
enzymic activation.
N-methyl-N-nitroso-N'-nitroguanidine (MNG) (I), and its homologue N-ethyl-
N-nitroso-N'-nitroguanidine (ENG) (II) resemble the respective alkylnitro-
sourethanes in some oftheir chemical and biological actions. Both these types of
alkylnitroso compounds are decomposed by alkali to form the respective diazo-
alkanes. In the presence of free sulphydryls they undergo decomposition at
pH 6-0-7-0, releasing nitrogen as gas and an alkylating moiety without the need of
enzymes. It is not certain whether diazoalkane is an intermediary in this reaction
with SH groups (Schoental, 1961, 1966, 1968 and unpublished results).
MNG has been reported to have an inhibitory effect on leukaemia (Greene and
Greenberg, 1960; Goldin, Vendetti and Kline, 1959) and mutagenic action on
various micro-organisms (Mandell and Greenberg, 1960; Eisenstark, Eisenstark
and Sickle, 1965; Gilham, 1965; Lingens and Oltmanns, 1966; Siu, 1968) and
viruses (Singer and Fraenkel-Conrat, 1967). It causes chromosomal aberrations
in plants (Gichner, Michaelis and Rieger, 1963; Kaul, 1969; Muller and Gichner,
1964) and permanent bleaching of chloroplasts in Euglena gracilis (McCalla, 1965).
In rats, MNG induced tumours of the squamous part of the stomach when a
few doses were given intragastrically (Schoental, 1966; Craddock, 1968a) and of
the glandular part of the stomach when given continuously as dilute solutions
in drinking water (Sugimura and Fugimura, 1967). On repeated subcutaneous
injections, it induced local sarcomata (Sugimura, Nagao and Okada, 1966;
Druckrey et al., 1966).
The ethyl-homologue ENG is less active on the basis of both inhibition of
ascites tumours (Greene and Greenberg, 1960) and of mutagenic action on
Arabidopsis thaliana (Gichner and Veleminsky, 1967) but has not been so exten-
sively studied. The carcinogenic effects do not appear to have been reported.
The respective alkylnitrosourethanes have been shown to induce mainly
tumours of the stomach when given intragastrically (Schoental, 1963) but pre-
dominantly intestinal tumours after intraperitoneal injections (Schoental an
Bensted, 1968). We now report similar dependence ofthe localisation oftumours
when MNG or ENG were given by the intragastric or the intraperitoneal route
to rats. MNG induced gastro-intestinal tumours also in mice.R. SCHOENTAL AND J. P. M. BENSTED
MATERIALS AND METHODS
Two strains of mice were used: C3H and CFW white. They were males, 1-2
months old at the beginning of the experiments, and were housed in metal cages,
6 per cage.
White rats, derived from the Porton Strain, bred randomly in the M.R.C.
Laboratories, Carshalton, were used. Weanling males and females were separated
according to sex and kept in metal cages about 5 rats per cage. They were weighed
at the beginning ofthe experiment and at monthly intervals or more often. Both
mice and rats were given the normal diet MRC 41B and water ad libitum. All the
animals that died or that were killed by coal gas when they appeared ill, were
autopsied, the livers, lungs, stomachs, kidneys and any other organs which
seemed abnormal were fixed in Helly or neutral 1O o formol salinesolution; sections
cut at 5-6 Iu were stained routinely with haematoxylin and eosin for microscopic
examination. Other stains were used when required.
The compounds MNG (I) and ENG (II) were commercial preparations supplied
by the Aldrich Chemical Co., Milwaukee, Wise. Both MNG and ENG were
crystalline preparations, only sparingly soluble in ethanol or water and were used
as suspensions in aqueous ethanol; the doses could therefore be estimated only
approximately.
CH3 CH2CH3
N NO N NO
C=NH C=NH
HN-NO2 R-NO2
N-methyl-N-nitroso-N'-nitroguanidine N-ethyl-N-nitroso-N'-nitroguanidine
I II
EXPERIMENTAL
The following experiments were performed:
A. N-Methyl-N-nitroso-N'-nitroguanidine (MNG)
1. Eight female and 6 male rats (50-90 g. body wt) were given a suspension
of MNG in 30% aqueous ethanol by gastric intubation, 50-100 mg./kg. body
weight.
In the course of the first year they were given additionally 1-4 doses not exceeding
50 mg./kg. body weight in a similar way.
2. Twelve male rats (40-55g. body weight) were given MNG, by intraperitoneal
injection, about 60 mg./kg. body weight in 0-1 ml. followed by additional 2-3
smaller doses 10-25 mg./kg. body weight within the first 11 months. Thereafter
they were left without further treatment.
3. Twelve male mice, CFW were given 0*05-0*1 ml. of a suspension of MNG
by intraperitoneal injections corresponding to approximately 1-2 mg./mouse.
Two more similar doses were given 8 and 10 months afterthefirstdose,respectively.
4. Twelve male C3H mice received similarly MNG, by intraperitoneal injection.
Two doses of 2 mg./mouse each (100 mg./kg. and 60 mg./kg. body weight respec-
tively) were given at 6 monthly interval.
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5. Six male C3H mice were given a single dose of MNG 2-5 mg./mouse (125
mg./kg. body weight) by gastric intubation.
6. Six male C3H mice were given a single dose of MNG, 1-2 mg./mouse by
subcutaneous injection.
B. N-Ethyl-N-nitroso-N'-nitroguanidine (ENG)
1. Four female and 6 male white rats (45-75 g. body weight) were given a
suspension of ENG in 3000 aqueous ethanol by gastric intubation 20-70 mg./kg
body weight, followed by three additional doses given within 10 months.
2. Two females were given a single dose of ENG, 100 mg./kg. by gastric
intubation.
3. Twelve male rats (40-55 g. body weight) were given by intraperitoneal
injection suspensions of ENG, about 30 mg./kg. body weight followed by three
additional doses not exceeding 20 mg./kg. body weight within 10 subsequent
months.
4. Twelve white male CFW mice, about 1 month old, were given by intra-
peritoneal injection I mg. of ENU, followed by two more doses within 10 months.
5. Twelve male C3H mice were given two doses ENU by intraperitoneal
injection of approximately 2 mg./mouse.
RESULTS
A. N-Methyl-N-nitroso-N'-nitroguanidine (MNG)
In Table I are summarised the dosage schedules and the times of survival of rats
which had significant lesions.
1. Of the 8 female rats all but one survived well over a year (1-2 years).
Three rats had squamous cell carcinomata of the stomach with metastatic spread.
One ofthese 3 rats showed, in addition, a highly anaplastic adenocarcinoma ofthe
glandular portion of the stomach (Fig. 1, 2). Another of these rats had also a
thymoma in the mediastinum (Fig. 3) and a further one had hyperplastic papillo-
matous changes in the squamous portion of the stomach.
An unusual multi-lobulated, polycystic appearance of the liver was observed
in one rat (Fig. 4) associated with a large intraperitoneal (low grade) fibrosarcoma.
2. Among the 6 male rats, only 3 survived longer than 1 year (12-14 months)
and all the three had squamous papillomata ofthe stomach (Fig. 5). Another had
anaplastic peritoneal tumour (? primary).
3. Among the 12 male rats given intraperitoneal injections of MNG. the
distribution of gastro-intestinal tumours was rather more widespread. Two
rats had gastric tumours, 1 of which was an histologically proven squamous cell
carcinoma. The jejunum of a third rat showed an adenocarcinoma whilst in 2
others the caecum was the site of a carcino-sarcoma and a round-cell sarcoma.
A subcutaneous, very anaplastic sarcoma, was observed in another rat, possibly
related to the needle track.
In Table II are sumunmarised the dosage schedules, and the times of survival of
mnice that had significant lesions.
1. Among the 12 CFW mice, given MNG by intraperitoneal injections one had
a vascular caecal tumour and another an adrenal cortical tumour. No gastric
tumours were observed.
759R. SCHOENTAL AND J. P. M. BENSTED
TABLE I.-Significant Lesions Found in Rats Given N-methyl-N-nitroso-N'-nitroguanidine
Sex
(total Dose (mg./rat) at times of treatment:
treated r A Total dose Survival
26) 0 11 days 28 days 6 mth 10 mth (mg./rat) Route (months) Significant pathology
9 . 5 5 5 10 16 . 41 . i.g. . 11-5K . Somach-wartypapillomata
9? . 2 5 2 5 - - 16 . 21 . i.g. 15 K . Stomach-squamouscell
carcinoma.
S9 . 5 5 5 . 15 . i.g. . 20 K . Liver-multi-loculated,
polycystic changes.
9? . 4 4 5 10 16 . 39 . i.g. 24 K . Stomach-squamous
carcinoma and adeno-
carcinoma.
0
9 . 5
(' . 5
( . 5
& .5
& .5
0 6 mth 9 mth 1
5 mth 9 mth
10 16 . 31 . i.g. . 24 K . Stomach-squamous cell
carcinoma, thymoma.
- 16 . 21 . ig. . 10 D . Anaplastic peritoneal
tumour. ?Primary.
10 16 . 31 . i.g. . 12 K . Stomach-warty
papillomata.
10 16 . 31 . i.g. . 14 K Stomach-warty
papillomata.
10 16 . 31 . i.g. . 14 K . Stomach-warty
papillomata.
1 mth
& . 3 3 5 12 - . 23 . i.p. . 12 K . Caecum-round cell
sarcoma.
&! . 3 3 5 12 . 23 . i.p. . 14 K . Jejunum-adenocarcinoma.
T . 3 3 5 12 - . 23 . i.p. . 15 K . Caecum-carcinosarcoma.
&3 . 3 3 5 12 . 23 . i.p. . 15 K . Peritoneum-chronic fungal
infection (?sporotrichosis)
T . 3 2 5 - . 10 . i.p. . 16 K . Subcutaneous sarcoma at
injection site.
(3' . 3 2 5 12 . 22 . i.p. . 18 K . Stomach-squamous cell
carcinoma.
CT . 3 3 5 12 . 23 . i.p. . 19 D . Stomach-macroscopic
tumour.
TABLE II.-Main Lesions Found in Mice Treated With N-methyl-N-nitroso-N'-nitroguanidine
C
Dose (mg./mouse) at
times of treatment:
_A Total dose Survival
Strain 0 8 mth 10 mth (mg./mouse) Route (months)
-FW (&) . 1 1 1 . 3 . i.p. . 14 D
(12) . 1 1 1 . 3 . i.p. . 14K A_ I _1 t . C3H (&)
(24)
0
1
1
1
1
1
1
1
2-5
2-5
2 5
2-5
2-5
6 mth
3
2
2
2
2
2
2
1 *2
1 *2
1 *2
1 *2
1 *2
Significant/Pathology
. Caecum-angiosarcoma.
. Adrenal cortical tumour.
3 . i.p. . 9 5 K . Liver-hepatoma.
3 . i.p. 13 D . Caecum-adenocarcinoma; Liver and
spleen-haemangiomatous changes.
3 . i.p. . 13 K . Ileum-adenoma.
3 . i.p. . 16 K . Jejunum-adenocarcinoma.
3 . i.p. 16 K . Liver-hepatoma; Lung-adenoma.
3 . i.p. 16 K . Liver-hepatoma; Lung-adenoma.
3 . i.p. . 16 K . Liver-hepatoma; Lung-adenoma.
2-5 . i.g. . 11 D . Keratinising squamous cell.
2-5 . i.g. 11 K Somach squamous cell carcinoma.
2*5 . i.g. 14 D . Stomach squamous cell carcinoma.
2-5 . i.g. . 20 K . Small bowel-adenoma; Liver-adenoma.
2-5 . i.g. . 21 K . Liver-polycystic appearance; Lung-
adenoma; Stomach-squamous
papilloma; Lymph node-reticulum cell
tumour.
1-2 . s.c. . 17 D . Lung adenoma.
1-2 . s.c. . 20 D . Lung adenoma.
1 2 . s.c. . 20 K . Lung adenoma.
1*2 . s.c. . 21 K . Liver-hepatoma; Lung-adenoma.
1*2 . s.c. . 21 K . Liver-hepatoma; Lung-adenoma.
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2. Among the 12 C3H mice given MNG by the intraperitoneal route, one
showed a caecal adenocarcinoma with multiple angiomatous changes in the liver
and spleen. The jejunum was the site of an adenocarcinoma (Fig. 6) in one case
and the ileum the site of a sessile adenoma in another. Small hepatomata and
pulmonary adenomata were present in 4 mice.
3. Among 6 C3H mice given MNG by stomach tube, 3 developed squamous
carcinomata (Fig. 7), one had a papilloma of the stomach, one had an adenoma
ofthe small bowel, one had a lung adenoma and another a hepatomata.
4. Among 6 C3H mice given a single dose of MNG subcutaneously, 5 had
lung adenomas and 1 had a hepatoma.
TABLE III.-Significant LesionsFound in Rats Treated With N-ethyl-N-nitroso-N'-nitroguanidine
Sex
(total (Dose (mg./rat) at times of treatment:
treated Total dose Survival
24) 0 11 days 28 days 10 mth (mg./rat) Route (months) Significant pathology.
5 i- - . 5 . ig. . 16- 5 . Polyarteritis.
2*5 2*5 5 5 . 15 . i.g. . 24 K . Breast-cystic fibro-adenosis.
5 - . 5 . i.g. . 24 K . Breast-adenocarcinoma.
0 5 mth 7 mth 9 mth
(3' . 5 20 16 . 41 . i.g. . 14 K . Stomach-wartypapillomata. (3' . 5 20 20 16 . 61 . i.g. . 26 K . Stomach-wartypapillomata.
0 6 mth 9 mth 10 mth
(3' . 3 4*5 5 5 . 17-5 . i.p. . I K . Ileum-polypoid adeno-
carcinoma.
(3' . 3 4 5 5 5 . 17*5 . i.p. . 14 K . Ileum-adenomatous polyp.
(3' . 3 4.5 5 5 . 17*5 . i.p. . 24 K . Lung-anaplastic tumour;
Liver-hepatoma.
&¢ . 3 4-5 5 5 . 17*5 . i.p. . 20 D . Subcutaneous fibroma.
B. N-ethyl-N-nitroso-N'-nitroguanidine (ENG)
In Table III are summarised the dosage patterns and timees of survival of rats
which hIad significant lesions.
1. No gastro-intestinal tumours, benign or malignant were found in the female
rats given ENG by stomach tube. In the mammary tissues of 2 rats, cystic
fibradenosis was seen in one rat and in the other, an adenocarcinoma.
In 2 ofthe 6 male rats given ENG by stomach tube, warty papillomata of the
stomach were present.
2. Ofthe 12 male rats given intraperitoneal injections of ENG, one was found
to have a very large adenocarcinoma nearthecaecum. Histologically,thistumour
was found to contain metaplastic bone (Fig. 8 and 9). A small adenomatous polyp
was noted in another rat, but no gastric tumours were seen. One rat, the longest
survivor in the group, showed an anaplastic lung tumour together with a liver
hepatoma. One rat had a large subcutaneous fibroma.
Mice
1. No gastro-intestinal tumours were found in the CFW mice. One mouse
had a widespread reticulum-cell tumour with evidence ofpulmonary adenomatosis.
2. No gastro-intestinal lesions were seen in the C3H mice given ENG. One
mouse had a hepato-cellular carcinoma and 6 others showed both hepatomata and
pulmonary adenomata.R. SCHOENTAL AND J. P. M. BENSTED
Although we have made no mention of a control series of rats and mice, it
has been our experience over several years in this laboratory that spontaneous
gastro-intestinal tumours are extremely rare (compare: Stewart et al., 1961;
Rowlatt, 1967).
DISCUSSION
Both compounds, MNG and ENG, are sparingly soluble in water and inorganic
solvents. They have been administered, therefore, as suspensions of crystals,
making the estimation of the dose only approximate. Having found previously
that the related alkylnitrosourethanes can induce gastro-intestinal tumours with
one or a few doses (Schoental, 1961; Schoental and Magee, 1962; Schoental and
Bensted, 1968), it appeared of interest to test whether the same applied to the
respective alkylnitrosoguanidines. The present experiments, in which the mini-
mal dosage able to induce tumours was explored, show that both MNG and ENG
are carcinogenic, and that, as in the case of the alkylnitrosourethanes, the methyl
compound is the more effective carcinogen.
The relative frequency of squamous gastric lesions, benign and malignant in
our animals given suspensions of MNG by stomach tube compares well with the
results of Craddock (1968a), who observed squamous carcinomata of the stomach
in all the 6 rats given one to four doses ofMNG (100 mg./kg. body weight each) as
a suspension. However, the tumours described by Sugimura and Fujimura (1967),
who administered MNG as dilute solutions in drinking water (33 or 83 mg. per litre)
continuously, for periods up to 1 year, appeared to be exclusively ofthe glandular
stomach. The factors responsible for these differences in tumour type are not
yet clear. Whilst we have no direct evidence, the gross appearance of the
stomach (Fig. 5) suggests multifocal derivation of the squamous tumours which
might be compatible with the deposition ofMNG particles in these areas.
Apart from thisfact, dose differences may play a part. On the assumption that
a rat will drink about 10 ml. of water per day, the total ingestion of MNG over a
EXPLANATION OF PLATES
FIG. 1.-Squamous and adenocarcinomatous gastric tumours in a female rat killed 24 months
after the first of five intragastric doses of MNG. H. and E. x 3.
FIG. 2. Mucinous adenocarcinoma of the glandular part of the stomach shown in Fig. 1.
(Arrow) H. and E. x 30.
FIG. 3.-Highly invasive squamous cell carcinoma of the stomach associated with a thymic
tumour in a female rat, killed 24 months after the first of three intragastric doses of MNG.
The liver showed sub-capsular haemangiomata and severe centri-lobular atrophy. x 1-25.
Fia. 4.-Liver and abdominal mass from a female rat killed 20 months after the first of three
intragastric doses ofMNG. Note the polycystic appearance ofthe liver. Kidney showed no
cystic changes. The abdominal mass proved to be a fibrosarcoma oflow grade malignancy.
FIG. 5.-Stomach of a male rat killed 14 months after the first of three intragastric doses of
MNG, showing extreme warty papillomatous appearance of the squamous part.
FIG. 6. Infiltrating adenocarcinoma of the small intestine of a C3H mouse, associated with an
intussusception, killed 16 months after the first of two doses of MNG. H. and E. x 27.
FIG. 7.-Keratinising squamous cell carcinoma of the stomach of a male C3H mouse killed 11
months after a single intragastric dose of MNG. H. and E. x 16.
FIG. 8. A large well-differentiated polypoid carcinoma of the terminal ileum in a rat killed 11
months after the first of four intraperitoneal doses of ENG.
FIG. 9. High power view of the tip of tumour depicted in Fig. 8. to show the metaplastic bone
present in the tumour stroma. H. and E. x 25.
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period of 12 months in experiments of Sugimura and Fugimura (1967) would be
approximately 120 mg. or 300 mg. per rat. This is over 3-15 times the total
amount of MNG administered to our rats.
The occurrence of cystic biliary lesions in the liver (Fig. 4) after intragastric
administration of suspensions ofMNG was described also by Craddock (1968).
MNG has been reported to induce sarcomata in rats, at the site of repeated
subcutaneous injections. The total dosage corresponded to 10 or 25 mg. per
rat given in 10 weekly doses (Sugimura, Nagao and Okada, 1966) and 225 or 450
mg./kg. body weight given in 5 weekly doses (Druckrey et al., 1966).
There have not yet been reports oftesting MNG and ENG in mice. Tlle dosage
in the present experiments was minimal; the development of a few gastro-
intestinal tumours with MNG indicates that mice are also susceptible to its
carcinogenic action. The hepatomas and lung adenomas found in C3H mice
cannot, however, be attributed to the action of MNG (or ENG). This strain of
mice is known to develop spontaneously a high incidence of hepatomas and some
lung adenomas (Heston, Vlahakis and Deringer, 1960; compare also Hoag,
1963).
ENG induced in rats tumours of the intestines with intraperitoneal injections
ofas little as 17-5 mg./rat; it is ofinterest that one rat had a hepatoma and another
a fibrosarcoma in this series. The latter might have been related to the needle
tract.
No gastro-intestinal tumours have been seen in female rats given doses not
exceeding 15 mg./rat in toto; 9 warty papillomas were found in the stomachs of
two rats that had a total dosage of 41 and 61 mg. ENG/rat, respectively.
From these experiments it is obvious that the alkylnitrosoguanidines, MNG
and ENG exert similar carcinogenic effects to the alkylnitrosourethanes. The
biological similarity of action has its counterpart in their chemical reactivities,
especially as regards free thiols. It is ofinterest that at about pH 6 MNG interacts
with thiol groups and this pH has been found to be optimal for its mutagenic
action (Adelberg, Mandel and Chen, 1965; Siissmuth and Lingens, 1968, 1969).
The similarity of action extends also to the ability of both MNU and MNG to
alkylate nucleic acids mainly at the 7-position of guanine (Schoental, 1967
Craddock, 1968b). The extent of alkylation of DNA in vitro has been reported to
increase in the presence of cysteine with both, MNU (Schoental, 1967) and MNG
(Lawley, 1.968; McCalla, 1968; Stissmuth and Lingens, 1968). However, the
significance of the alkylation of nucleic acids for the mechanism of their carcino-
genic action is not clear; no correlation could be found between the extent of
alkylation by MNU ofDNA or RNA in various ratorgansinvivoandthelocalisation
of tumours induced by this compound (Schoental, 1969).
In view of the strong carcinogenic action of MNG, its use in childhood leukae-
mias, or as an antimalarial agent (Siu, 1968) is not advisable.
SUMMARY
Alkylnitrosoguanidines, the methyl and the ethyl homologues induce in rats
mainly tumours of the stomach, when given intragastrically, and tumours of the
intestines when injected intraperitoneally. Mice are also susceptible to these
compounds, which, like the respective alkylnitrosourethanes, yield an alkylating
entity on interacting with sulphydryls, without the need of enzymic activation.
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